Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis

Bilbao, J.I.; Sangro, Bruno; Longo, Jesús M.; Zozaya, J. M.; Fernández-Virgós, Amelia; Aquerreta, Jesús Dámaso; Beloqui, Óscar; Prieto, Jesús

doi:10.1016/0720-048x(92)90109-m

European Journal of Radiology

1992

DOI: 10.1016/0720-048x(92)90109-m

|View full text |Cite

Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis

J.I. Bilbao¹,

Bruno Sangro²,

Jesús M. Longo³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1995

2014

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There were no modifications in the white cells. The clinical course in our patient was similar to that described by others [3,6], with moderate fever for 3 days, mild abdominal pain and vomiting (known as the postembolization syndrome) and alleviated by symptomatic treatment [2]. We did not observe any other complications (e.g.…”

supporting

confidence: 60%

“…PSE is an accepted therapy for the treatment of secondary hypersplenism in various disorders, including oesophageal variceal haemorrhage [3], thalassaemia major [5], portal hypertension [1], painful splenomegaly [2], Gaucher disease [9], hypersplenism in cirrhosis [5], and prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis [2,3].…”

mentioning

confidence: 99%

See 1 more Smart Citation

Partial splenic embolization in a child with hereditary spherocytosis

Moreno-Jiménez

Azcona

et al. 1995

Eur J Pediatr

View full text Add to dashboard Cite

Partial splenic embolization (PSE) was introduced as an alternative to splenectomy to avoid the risk of post-splenectomy sepsis and to reduce the number of situations in which surgery would be dangerous or not feasible [5]. PSE is an accepted therapy for the treatment of secondary hypersplenism in various disorders, including oesophageal variceal haemorrhage [3] As an alternative to surgical splenectomy, PSE was performed on a 7-year-old girl with hereditary spherocytosis and hypersplenism who initially presented with a haemolytic crisis; haemoglobin values of 6.8 g/dl, jaundice and splenomegaly. She needed blood transfusions on two occasions due to persistent anaemia, with Hb values between 6.8-9 g/dl. PSE was performed following the Spigos protocol [8].Peripheral blood cell counts were repeated on days 1, 3, 7 and 15, and then 1, 3, 6, and 12 months after PSE (see Table 1). Abdominal ultrasound 1 month after PSE showed a 17% reduction in spleen size, with embolization of approximately 75% of the spleen.Maddison [7] performed the first successful splenic arterial embolization in 1973. The procedure was initially associated with significant morbidity and mortality, but subsequent series report substantially improved results [6]. We performed the embolization technique described by Spigos [1,3,6,8] because it has a very low risk of complications, although Israel et al. [5] recently reported a lower rate of complications using polyvinyl alcohol.The increase in haemoglobin values found in our patient has been observed in patients affected by other diseases who have required PSE [5]. The thrombocytosis observed in our patient during the first 15 days after PSE that returned to normal values over 3 months, has been previously reported [3,5]. This increase in platelet count appears to be

show abstract

supporting

confidence: 60%

mentioning

confidence: 99%

Partial splenic embolization in a child with hereditary spherocytosis

Moreno-Jiménez

Azcona

et al. 1995

Eur J Pediatr

View full text Add to dashboard Cite

show abstract

Guidelines on the use of gelatin sponge particles in embolotherapy

et al. 2014

View full text Add to dashboard Cite

Gelatin sponge (GS) is one of the most widely used embolic agents in interventional procedures. There are four commercially available GS products in Japan; however, the endovascular use of Gelfoam and Spongel is off-label, and Gelpart can only be used for hepatic artery embolization and Serescue can only be used for hemostasis of arterial bleeding. GS has been used for a variety of clinical indications, mainly tumor embolization and stopping massive arterial bleeding. The optimal size and preparation procedure of GS particles differs slightly for each clinical indication. In addition, there is a risk of ischemic and/or infectious complications associated with GS embolization in various situations. Therefore, radiologists should be familiar with not only the preparation and handling of GS particles, but also the disadvantages and potential risks, in order to perform GS embolization safely and effectively.

show abstract

Recent role of Hassab's operation for cirrhotic patients: Combination with endoscopic procedure for varices

Hayashi

Takamura

Yamaguchi

et al. 2012

Asian Journal of Surgery

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis

Cited by 6 publications

References 17 publications

Partial splenic embolization in a child with hereditary spherocytosis

Partial splenic embolization in a child with hereditary spherocytosis

Guidelines on the use of gelatin sponge particles in embolotherapy

Recent role of Hassab's operation for cirrhotic patients: Combination with endoscopic procedure for varices

Contact Info

Product

Resources

About